GENEVA, April 7 -- HANMI PHARM. CO., LTD. (214, Muha-ro, Paltan-myeon,Hwaseong-si,Gyeonggi-do 18536), 한미약품 주식회사 (경기도화성시팔탄면 무하로 214) filed a patent application (PCT/KR2024/014757) for "NUCLEIC ACID MOLECULE COMPRISING MODIFIED POLYADENYLATION SEQUENCE AND OX40L PROTEIN-CODING SEQUENCE" on Sep 27, 2024. With publication no. WO/2025/071347, the details related to the patent application was published on Apr 03, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s):...